Asset Dedication LLC’s CONMED CNMD Stock Holding History

Asset Dedication LLC’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10	Closed	-$1K	–	670
2019 Q4	$1K	Buy	+10	New	+$1.07K	﹤0.01%	700

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Asset Dedication LLC's CNMD Position: Q1 2020 in Review

Asset Dedication LLC sold out of CONMED (CNMD) in Q1 2020, closing a stake of 10 shares — an estimated $1K sold.

Asset Dedication LLC first reported a position in CNMD in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 229 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

Asset Dedication LLC reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
Asset Dedication LLC sold 10 CONMED shares in Q1 2020, an estimated $1K.
Asset Dedication LLC first reported a position in CONMED in Q4 2019 and held it in 1 quarter.
Asset Dedication LLC's CONMED position peaked at $1K in Q4 2019.
229 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Asset Dedication LLC's 13F filing for Q1 2020, filed 5 May 2020.